Zhao Ni Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Zhao Ni Wang has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- De Yun Wang
Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
2 shared publications - Hui-Qin Zhou
Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center, The Fifth Affiliated Hospital, Sun Yat-Sen University, Zhuhai, China
1 shared publication - Jing Liu
Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117545, Singapore
1 shared publication - Kai Sen Tan
Department of Otolaryngology, National University of Singapore, Singapore, Singapore
1 shared publication Kim Thye Thong
Department of Otolaryngology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
1 shared publication- Liu-Tong Yi
Department of Pathology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China
1 shared publication
Latest Publications
- Open Access
- 29 January 2022
- Published by Elsevier in Military Medical Research
- Vol. 9 (1) , 1-16
FGF2 is overexpressed in asthma and promotes airway inflammation through the FGFR/MAPK/NF-κB pathway in airway epithelial cells
- 29 January 2022
- Published by Elsevier in Military Medical Research
- Vol. 9 (1) , 1-16
Open AccessFGF2 is overexpressed in asthma and promotes airway inflammation through the FGFR/MAPK/NF-κB pathway in airway epithelial cells
- Open Access
- 15 July 2019
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 19 (1) , 1-11
Upregulation of cell-surface mucin MUC15 in human nasal epithelial cells upon influenza A virus infection
Cell-surface mucins are expressed in apical epithelial cells of the respiratory tract, and contribute a crucial part of the innate immune system. Despite anti-inflammatory or antiviral functions being revealed for certain cell-surface mucins such as MUC1, the roles of other mucins are still poorly understood, especially in viral infections. To further identify mucins significant in influenza infection, we screened the expression of mucins in human nasal epithelial cells infected by H3N2 influenza A virus. We found that the expression of MUC15 was significantly upregulated upon infection, and specific only to active infection. While MUC15 did not interact with virus particles or reduce viral replication directly, positive correlations were observed between MUC15 and inflammatory factors in response to viral infection. Given that the upregulation of MUC15 was only triggered late into infection when immune factors (including cytokines, chemokines, EGFR and phosphorylated ERK) started to peak and plateau, MUC15 may potentially serve an immunomodulatory function later during influenza viral infection. Our study revealed that MUC15 was one of the few cell-surface mucins induced during influenza infection. While MUC15 did not interact directly with influenza virus, we showed that its increase coincides with the peak of immune activation and thus MUC15 may serve an immunomodulatory role during influenza infection.
- 15 July 2019
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 19 (1) , 1-11
Open AccessUpregulation of cell-surface mucin MUC15 in human nasal epithelial cells upon influenza A virus infection
Cell-surface mucins are expressed in apical epithelial cells of the respiratory tract, and contribute a crucial part of the innate immune system. Despite anti-inflammatory or antiviral functions being revealed for certain cell-surface mucins such as MUC1, the roles of other mucins are still poorly understood, especially in viral infections. To further identify mucins significant in influenza infection, we screened the expression of mucins in human nasal epithelial cells infected by H3N2 influenza A virus. We found that the expression of MUC15 was significantly upregulated upon infection, and specific only to active infection. While MUC15 did not interact with virus particles or reduce viral replication directly, positive correlations were observed between MUC15 and inflammatory factors in response to viral infection. Given that the upregulation of MUC15 was only triggered late into infection when immune factors (including cytokines, chemokines, EGFR and phosphorylated ERK) started to peak and plateau, MUC15 may potentially serve an immunomodulatory function later during influenza viral infection. Our study revealed that MUC15 was one of the few cell-surface mucins induced during influenza infection. While MUC15 did not interact directly with influenza virus, we showed that its increase coincides with the peak of immune activation and thus MUC15 may serve an immunomodulatory role during influenza infection.